NADAL® HAV IgG/IgM test cassette


30 individually packed test cassettes for detection and differentiation of anti-hepatitis A virus (HAV) IgG and IgM in human serum, plasma or whole blood


Package contents:

30 test cassettes

30 capillary tube (5 µL)

1 buffer (5 mL)

1 package insert

Exclusively for professional users

Discover more than 2,000 medical and toxicological tests and POCT solutions

Please note: The prices shown are basic list prices. Your individual prices will be displayed after you have logged in to the shop. Your personal customer advisors can add them at any time.

Sign in/Register

We are at your service under the following contact options:
+49 (0)941-29010-0 or info(at)

Or simply use our contact form

Product description

The NADAL® HAV IgG/IgM Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of anti-hepatitis A virus (HAV) IgG and IgM in
human serum, plasma or whole blood. The test is intended to be used by professionals as a screening test and as an aid in the diagnosis of a HAV infection. Any reactive result with the NADAL® HAV IgG/IgM Test must be confirmed with alternative testing method(s) and clinical findings.

First isolated in 1973, the hepatitis A virus (HAV) is a nonenveloped RNA virus of the family Picornaviridae, genus Hepatovirus. Its transmission occurs primarily through serial
transmissions from person to person by the fecal-oral route. However, HAV can also be contracted from contaminated water, close personal contact, sexual contact, and illicit drug
use. Following an incubation period of approximately 28 days (15-50 days), the disease is characterised by a rapid onset of symptoms. Signs and symptoms can include nausea, vomiting,
diarrhea, dark urine, jaundice, fever, headaches, weight loss and abdominal pain. The likelihood of symptoms increases with age. Normally, acute illness does not last more than two
months. There is no chronic viral shedding and no chronic stage of the disease, though recurrences, acute fulminant hepatitis and other complications may occur. Anti-HAV IgM
are detectable at or prior to the onset of clinical illness and decline in about 3 to 6 months. Anti-HAV IgG appear soon after IgM, persist for years after infection and confer lifelong
immunity. The presence of anti-HAV IgG and the absence of anti-HAV IgM can be used to differentiate between past and current infections. IgM assays can detect antibodies in
individuals who have recently received a hepatitis A vaccine for a short period of time. However, lower concentrations detected 4 to 6 months after the onset of infection typically
do not produce a positive test result. The NADAL® HAV IgG/IgM Test detects and differentiates anti-HAV IgG from anti-HAV IgM in human serum, plasma or whole blood after 15 minutes and can be performed by minimallyskilled personnel without the use of laboratory equipment.

More Information

More Information
SKU 622070N-30
Testformat test cassette
Test evaluation Provides a qualitative test result
Sample type Serum, Whole Blood, Plasma
Detected parameter HAV IgG/IgM
Package size 30 individually packed test cassettes
Detection time Test result after 15 minutes
Storage temperature The test should be stored at 2 - 30 °C
CE-Label Yes
Pathogentype Viral infection

We found other products you might like!


No files available.


No files available.

Copyright @2023 nal von minden GmbH. All rights reserved.